Stereotactic body radiotherapy of primary and metastatic renal lesions for patients with only one functioning kidney

References

• Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005; 16: 481–8
   PubMed Web of Science ®Google Scholar
• Motzer RJ, Hutson TE, Tomczak P, Michaelsson MD, Bukowski RM, Rixe O, et al. Sutinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 2007; 356: 115–24
   PubMed Web of Science ®Google Scholar
• Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Siebels M, et al. Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 2007; 356: 125–34
   PubMed Web of Science ®Google Scholar
• Bani-Hani AH, Leibovich BC, Lohse CM, Cheville JC, Zincke H, Blute ML. Associations with contralateral recurrence following nephrectomy for renal cell carcinoma using a cohort of 2,352 patients. J Urol 2005; 173: 391–4
   PubMedGoogle Scholar
• Malek RS, Omess PJ, Benson RC, Jr, Zincke H. Renal cell carcinoma in von Hippel-Lindau syndrome. Am J Med 1987; 82: 236
   PubMedGoogle Scholar
• Grimaldi G, Reuter V, Russo P. Bilateral non-familial renal cell carcinoma. Ann Surg Oncol 1998; 5: 548
   PubMedGoogle Scholar
• Stephens R, Graham SD, Jr. Enucleation of tumor versus partial nephrectomy as conservative treatment of renal cell carcinoma. Cancer 1990; 65: 2663
   PubMed Web of Science ®Google Scholar
• Gohji K, Kamidono S, Yamanaka N. Renal carcinoma in a solitary kidney. Br J Urol 1990; 66: 248
   PubMedGoogle Scholar
• Novick AC, Stewart BH, Straffon RA, Banowsky LH. Partial nephrectomy in the treatment of renal adenocarcinoma. J Urol 1977; 118: 932
   PubMed Web of Science ®Google Scholar
• Henriksson C, Geterud K, Aldenborg F, Zachrisson BF, Pettersson S. Bilateral asynchronous renal cell carcinoma. Computed tomography of the contralateral kidney 10–43 years after nephrectomy. Eur Urol 1992; 22: 209
   PubMedGoogle Scholar
• Bhayani SB, Allaf ME, Link RE, Rao P, Varkarakis JM, Jarrett TW, et al. Laparoscopic partial nephrectomy in patients with neoplasia in a solitary kidney. Urology 2004; 64: 35–7
   PubMed Web of Science ®Google Scholar
• Marshall FF, Taxy JB, Fishman EK, Chang R. The feasibility of surgical enucleation for renal cell carcinoma. J Urol 1986; 135: 231
   PubMed Web of Science ®Google Scholar
• Varkarakis IM, Allaf ME, Inagaki T, Bhayani SB, Chan DY, Su LM, et al. Percutaneous radio frequency ablation of renal masses: Results at a 2-year mean followup. J Urol 2005; 174: 456–60
   PubMed Web of Science ®Google Scholar
• Qi DF, Wu KJ, Li X, Zeng GH, Chen WZ. Treating renal carcinoma with ablation or ablation combined with 125I seed implantation: A report of eleven cases. Ai Zheng 2005; 24: 587–90
   PubMedGoogle Scholar
• Lau WK, Blute ML, Weaver AL, Torres VE, Zincke H. Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc 2000; 75: 1236–42
   PubMed Web of Science ®Google Scholar
• Blomgren H, Lax I, Naslund I, Svanstrom R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 1995; 34: 861–70
   PubMed Web of Science ®Google Scholar
• Gunven P, Blomgren H, Lax I. Radiosurgery for recurring liver metastases after hepatectomy. Hepatogastroenterology 2003; 50: 1201–4
   PubMedGoogle Scholar
• Lax I, Blomgren H, Naslund I, Svanstrom R. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol 1994; 33: 677–83
   PubMed Web of Science ®Google Scholar
• Wulf J, Haedinger U, Oppitz U, Thiele W, Mueller G, Flentje M. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: A noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 2004; 60: 186–96
   PubMed Web of Science ®Google Scholar
• Wersall PJ, Blomgren H, Lax I, Kalkner KM, Linder C, Lundell G, et al. Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. Radiother Oncol 2005; 77: 88–95
   PubMed Web of Science ®Google Scholar
• Svedman C, Sandström P, Pisa P, Blomgren H, Lax I, Kälkner K-M, et al. A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma. Acta Oncol 2006; 45: 870–5
   PubMed Web of Science ®Google Scholar
• Schwartz LH, Mazumdar M, Wang L, Smith A, Marion S, Panicec DM, et al. Response assessment classification in patients with advanced renal cell carcinoma treated on clinical trials. Cancer 2003; 98: 1611–9
   PubMedGoogle Scholar
• Kutcher GJ, Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume model. Int J Radiat Oncol Biol Phys 1989; 16: 1623–30
   PubMed Web of Science ®Google Scholar
• Lax I, Blomgren H, Larson D, Näslund I. Extracranial stereotactic radiosurgery of localized targets. J Radiosurgery 1998; 1: 135–48
   Google Scholar
• Lalich JJ, Faith GC, Harding GE. Protein overload nephropathy in rats subjected to unilateral nephrectomy. Arch Pathol 1970; 89: 548–59
   PubMedGoogle Scholar
• Kim TH, Sommerville PJ, Freeman CR. Unilateral radiation nephropathy the long-term significance. Int J Radiat Oncol Biol Phys 1984; 10: 2053–9
   PubMedGoogle Scholar
• Dewit L, Anninga JK, Hoefnagel CA, Nooijen WJ. Radiation injury in the human kidney: A prospective analysis using specific scintigraphic and biochemical endpoints. Int J Radiat Oncol Biol Phys 1990; 19: 977–83
   PubMed Web of Science ®Google Scholar
• Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991; 21: 109–22
   PubMed Web of Science ®Google Scholar
• Köst S, Dörr W, Keinert K, Glaser F-H, Endert G, Herrmann T. Effect of dose and dose-distribution in damage to the kidney following abdominal radiotherapy. Int J Radiat Biol 2002; 78: 695–702
   PubMed Web of Science ®Google Scholar
• Bani-Hani AH, Leibovich BC, Lohse CM, Cheville JC, Zincke H, Blute ML. Associations with contralateral recurrence following nephrectomy for renal cell carcinoma using a cohort of 2,352 patients. J Urol 2005; 173: 391–4
   PubMedGoogle Scholar